BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 2901773)

  • 1. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
    Rosenberg-Bourgin M; Gardet P; de Sahb R; Schlumberger M; Caillou B; Guilloud-Bataille M; Travagli JP; Feingold N; Parmentier C
    Henry Ford Hosp Med J; 1989; 37(3-4):141-3. PubMed ID: 2576948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of medullary carcinoma of the thyroid.
    Block MA
    Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family screening in medullary thyroid carcinoma presenting without a family history.
    Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
    Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer].
    Rochiccioli P; Tauber MT; Pienkowski C
    J Genet Hum; 1989 Sep; 37(3):207-14. PubMed ID: 2576280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine neoplasia type 2: familial variant of medullary carcinoma of the thyroid gland].
    Neradilová M; Soutorová M; Vlcek P
    Vnitr Lek; 1992 Sep; 38(9):850-9. PubMed ID: 1362306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for the familial form of medullary cancer of the thyroid].
    Allannic H
    Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
    Grauer A; Raue F; Gagel RF
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple endocrine neoplasia-type medullary thyroid carcinoma in three generations of a family].
    Takácsi NZ; Poller I; Trón L; Dabasi G; Rákóczy G; Füzy M; Szentirmay Z; Esik O
    Orv Hetil; 1998 Nov; 139(48):2883-8. PubMed ID: 9868902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of medullary thyroid carcinoma in multiple endocrine neoplasia type II].
    Ezabella MC; Hayashida CY; Bisi H; Leite MO; Borelli A; Abelin NM; Cordeiro AC; Camargo RY; Toledo SP
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(3):105-9. PubMed ID: 1983764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
    Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
    Rays; 2000; 25(2):257-66. PubMed ID: 11370543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.